Mays v. Bishop et al
Filing
31
STIPULATION AND ORDER STAYING ACTION PENDING OUTCOME OF ANNOUNCED ACQUISITION OF DEFENDANT JUNO THERAPEUTICS, INC. signed by Judge Ricardo S Martinez. The briefing schedule on Defendants' 28 Motion to Transfer is vacated; All other pretrial proceedings are stayed. (PM)
1
2
3
4
5
6
7
8
9
10
UNITED STATES DISTRICT COURT
WESTERN DISTRICT OF WASHINGTON
IN RE JUNO THERAPEUTICS, INC.
DERIVATIVE LITIGATION
Lead Case No.: C17-1356 RSM
(Derivative Action)
This Document Relates To:
STIPULATED MOTION AND
ORDER STAYING ACTION
PENDING OUTCOME OF
ANNOUNCED ACQUISITION OF
DEFENDANT JUNO
THERAPEUTICS, INC.
11
12
13
14
ALL ACTIONS.
15
16
17
18
19
20
21
22
23
24
25
26
27
28
STIPULATED MOTION AND ORDER STAYING
ACTION PENDING OUTCOME OF ANNOUNCED
ACQUISITION OF JUNO THERAPEUTICS, INC.
LEAD CASE NO.: C17-1356 RSM
WILSON SONSINI GOODRICH & ROSATI, P.C.
701 Fifth Avenue, Suite 5100, Seattle, WA 98104-7036
Tel: (206) 883-2500 • Fax: (206) 883-2699
Defendants Hans E. Bishop, Richard D. Klausner, Robert T. Nelsen, Howard H. Pien, Hal
1
2
V. Barron, Thomas O. Daniel, Anthony B. Evnin, Mary Agnes Wilderotter, Marc Tessier-
3
Lavigne, Steven D. Harr, and Mark J. Gilbert, and Nominal Defendant Juno Therapeutics, Inc.
4
(“Juno”) (collectively, “Defendants”), and plaintiffs David E. Mays and Paul Szollosi
5
(collectively, “Plaintiffs”), by and through their respective counsel, submit this Stipulated Motion
6
and Proposed Order pursuant to LR 10(g):
WHEREAS, on September 8, 2017, Plaintiff David E. Mays filed a putative shareholder
7
8
derivative action purportedly on behalf of Juno, and on November 6, 2017, Plaintiff Paul Szollosi
9
filed a similar putative shareholder derivative action purportedly on behalf of Juno;
10
WHEREAS, on December 5, 2017, the Court consolidated the two actions and ordered a
11
briefing schedule for Defendants’ Motion to Transfer (“Motion”), with Defendants’ motion to be
12
filed no more than fourteen days after the order, Plaintiffs’ opposition to be filed no more than 45
13
days later, and Defendants’ reply to be filed no more than 30 days after Plaintiffs’ opposition is
14
filed (Dkt. 27);
WHEREAS, pursuant to the December 5, 2017 consolidation order, Defendants filed their
15
16
Motion on December 19, 2017 (Dkt. 28);
17
WHEREAS, on January 22, 2018, Juno and Celgene Corporation (“Celgene”) announced
18
the signing of a definitive merger agreement in which Celgene has agreed to acquire Juno for $87
19
per share in cash (the “Acquisition”) pursuant to a tender offer for all outstanding shares of Juno
20
(“Tender Offer”);
WHEREAS, the Tender Offer is anticipated to close in Q1 2018 (i.e., by the end of March
21
22
23
24
2018);
WHEREAS, the parties agree that, if the Tender Offer is completed and the Acquisition
closes, Plaintiffs will no longer have standing to pursue these putative derivative actions;
25
WHEREAS, for the purpose of ensuring that this action proceeds in an efficient and
26
orderly fashion, counsel for the parties have conferred and agreed to suspend briefing on the
27
Motion and all other pretrial proceedings herein, pending the outcome of the Tender Offer and
28
STIPULATED MOTION AND ORDER STAYING
ACTION PENDING OUTCOME OF ANNOUNCED
ACQUISITION OF JUNO THERAPEUTICS, INC.
LEAD CASE NO.: C17-1356 RSM
-1-
WILSON SONSINI GOODRICH & ROSATI, P.C.
701 Fifth Avenue, Suite 5100, Seattle, WA 98104-7036
Tel: (206) 883-2500 • Fax: (206) 883-2699
1
2
3
4
Acquisition;
NOW, THEREFORE, the undersigned parties, by and through their counsel of record,
hereby agree and stipulate to the following:
1.
The briefing schedule on Defendants’ Motion as ordered by the Court on
December 5, 2017 is vacated;
5
6
2.
All other pretrial proceedings are stayed;
7
3.
In the event the Acquisition fails to close, the parties agree to meet and confer in
8
good faith to agree on a new schedule for the filing of Plaintiffs’ Opposition to the
9
Motion and Defendants’ Reply in support of the Motion, as well as the hearing on
10
the Motion.
Respectfully submitted,
11
12
Dated: January 29, 2018
13
14
15
16
Counsel for Defendants
17
18
WILSON SONSINI GOODRICH & ROSATI, PC
/s/ Gregory L. Watts
Gregory L. Watts, WSBA #43995
701 Fifth Avenue, Suite 5100
Seattle, Washington 98104
Telephone: (206) 883-2500
Facsimile:
(206) 883-2699
Email: gwatts@wsgr.com
Dated: January 29, 2018
22
ZWERLING, SCHACHTER & ZWERLING, LL
/s/ Dan Drachler
Dan Drachler (WSBA #27728)
1904 Third Avenue
Suite 1030
Seattle, Washington 98101
Telephone: (206) 223-2053
Facsimile: (206) 343-9636
ddrachler@zsz.com
23
Counsel for Plaintiffs
24
HARWOOD FEFFER LLP
Robert I. Harwood (pro hac vice)
Matthew M. Houston (pro hac vice)
Benjamin I. Sachs-Michaels (pro hac vice)
488 Madison Avenue, 8th Floor
New York, New York 10001
Telephone: (212) 935-7400
Facsimile: (212) 753-3630
-2-
19
20
21
25
26
27
28
STIPULATED MOTION AND ORDER STAYING
ACTION PENDING OUTCOME OF ANNOUNCED
ACQUISITION OF JUNO THERAPEUTICS, INC.
LEAD CASE NO.: C17-1356 RSM
WILSON SONSINI GOODRICH & ROSATI, P.C.
701 Fifth Avenue, Suite 5100, Seattle, WA 98104-7036
Tel: (206) 883-2500 • Fax: (206) 883-2699
rharwood@hfesq.com
mhouston@hfesq.com
bsachsmichaels@hfesq.com
1
2
GLANCY PRONGAY & MURRAY, LLP
Robert V. Prongay
Lesley F. Portnoy
1925 Century Park East, Suite 2100
Los Angeles, California 90067
Telephone: (310) 201-9150
Facsimile: (310) 201-9160
rprongay@glancylaw.com
lportnoy@glancylaw.com
3
4
5
6
7
Counsel for Plaintiff David E. Mays
8
THE WEISER LAW FIRM, P.C.
Robert B. Weiser
Brett D. Stecker (pro hac vice)
James M. Ficaro (pro hac vice)
22 Cassatt Avenue
Berwyn, PA 19312
Telephone: (610) 225-2677
Facsimile: (610) 408-8062
rw@weiserlawfirm.com
bds@weiserlawfirm.com
jmf@weiserlawfirm.com
9
10
11
12
13
14
Counsel for Plaintiff Paul Szollosi
15
16
17
*
*
*
IT IS SO ORDERED this 31st day of January 2018.
A
18
19
RICARDO S. MARTINEZ
CHIEF UNITED STATES DISTRICT JUDGE
20
21
22
PRESENTED BY:
23
Gregory L. Watts, WSBA #43995
701 Fifth Avenue, Suite 5100
Seattle, Washington 98104
Telephone:
(206) 883-2500
Facsimile:
(206) 883-2699
Email: gwatts@wsgr.com
24
25
26
27
28
Counsel for Defendants
STIPULATED MOTION AND ORDER STAYING
ACTION PENDING OUTCOME OF ANNOUNCED
ACQUISITION OF JUNO THERAPEUTICS, INC.
LEAD CASE NO.: C17-1356 RSM
-3-
WILSON SONSINI GOODRICH & ROSATI, P.C.
701 Fifth Avenue, Suite 5100, Seattle, WA 98104-7036
Tel: (206) 883-2500 • Fax: (206) 883-2699
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?